AANEM News Express

AANEM News Express

Science News: Natural History of "Pure" Primary Lateral Sclerosis

7/14/2021
 

Submitted by: Hristelina Ilieva, MD, PhD
Edited by: Betul Gondogdu, MD

Hassan A, Mittal SO, Hu WT, Josephs KA, Sorenson EJ, Ahlskog JE. Natural History of "Pure" Primary Lateral Sclerosis. Neurology. 2021;96(17):e2231-e2238. doi:10.1212/WNL.0000000000011771

Summary: This retrospective review of pure PLS patients seen at Mayo Clinic-Rochester over a 26 year period (1990-2016), describes clinical characteristics and laboratory findings of 43 patients. Of these, 25 (58%) were female; median onset-age was 50 years (range: 38-78), and median follow-up duration was 9 years (range:4- 36). The ascending paraparesis phenotype (N=30; 70%) was most common, followed by hemiparetic-onset (N=9; 21%) and bulbar-onset (N=4; 9%). Among the 30 paraparetic-onset cases, bladder symptoms (n=18; 60%) and dysarthria (n=15; 50%) were more common than pseudobulbar affect (n=9; 30%); and dysphagia (n=8; 27%).  By last follow-up 17/30 (56%) used a cane; 6 (20%) required a wheelchair. The paraparetic-variant, compared with hemiparetic and bulbar-onset, had youngest onset (48 vs. 56 vs. 60 years, respectively; p=0.02). Five patients died, 1 required a feeding tube, and none required permanent non-invasive ventilation. Two patients developed minor EMG abnormalities. The remainder 39 had persistently normal EMGs. Pure PLS did not convert to ALS after median 9 years disease duration in this population. After years of pure PLS, less than 5% had a more pervasive neurodegenerative disorder.

Comments: This is a comprehensive review of PLS patients in a single center with longitudinal follow up for a median of 9 years and provides useful information for clinicians with regards to diagnostic criteria and prognosis. 
 


View Related News Stories:

  EducationScience News NSEB


Recent AANEM News

Remembering George Kraft, MD, MS

The American Clinical Neurophysiology Society to Hold Another Townhall Meeting of Clinical Neurophysiology, Epilepsy, and Neuromuscular Fellowship Program Directors

Science News: Amyotrophic Lateral Sclerosis and Noninvasive Positive Pressure Ventilatory Support: "Nasal Noninvasive Ventilation" or "Noninvasive Ventilatory Support"?

CMS Finalizes Updates to Physician Fee Schedule

Advocacy in Action: State Liaison Leads the Way for Patient Advocacy in Washington and Beyond





Advertisement

ABEM

Advertisement

Donate

Advertisement